Flux (2): Comparison of molecular mutation and crossover operators for ligand-based de novo design

被引:41
作者
Fechner, Uli [1 ]
Schneider, Gisbert [1 ]
机构
[1] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, D-60323 Frankfurt, Germany
关键词
D O I
10.1021/ci6005307
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We implemented a fragment-based de novo design algorithm for a population-based optimization of molecular structures. The concept is grounded on an evolution strategy with mutation and crossover operators for structure breeding. Molecular building blocks were obtained from the pseudo-retrosynthesis of a collection of pharmacologically active compounds following the RECAP principle. The influence of mutation and crossover on the course of optimization was assessed in redesign studies using known drugs as template structures. A topological atom-pair descriptor grounded on potential pharmacophore points was used as a molecular descriptor, and the Manhattan distance between the template and candidate molecules served as a fitness function. Exclusive use of the crossover operator yielded few unique compounds and often resulted in premature convergence of the optimization process, whereas exclusive use of the mutation operator resulted in diverse high-quality structures. Combinations of crossover and mutation yielded the overall best results. The majority of the designed structures exhibit a chemically reasonable architecture; chiral centers are rare, and unfavorable connections of building blocks are infrequent. We conclude that this fragment-based design principle is suited as an idea generator for the automated design of novel leadlike molecules.
引用
收藏
页码:656 / 667
页数:12
相关论文
共 34 条
[1]   Hit and lead generation:: Beyond high-throughput screening [J].
Bleicher, KH ;
Böhm, HJ ;
Müller, K ;
Alanine, AI .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :369-378
[2]   Computational tools for structure-based ligand design [J].
Bohm, HJ .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1996, 66 (03) :197-210
[3]   Keynote review: Structural biology and drug discovery [J].
Congreve, M ;
Murray, CW ;
Blundell, TL .
DRUG DISCOVERY TODAY, 2005, 10 (13) :895-907
[4]   DESCRIPTION OF SEVERAL CHEMICAL-STRUCTURE FILE FORMATS USED BY COMPUTER-PROGRAMS DEVELOPED AT MOLECULAR DESIGN LIMITED [J].
DALBY, A ;
NOURSE, JG ;
HOUNSHELL, WD ;
GUSHURST, AKI ;
GRIER, DL ;
LELAND, BA ;
LAUFER, J .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1992, 32 (03) :244-255
[5]  
DARWIN C, 1975, ORIGIN SPECIES FACSI
[6]   FlexNovo: Structure-based searching in large fragment spaces [J].
Degen, Joerg ;
Rarey, Matthias .
CHEMMEDCHEM, 2006, 1 (08) :854-868
[7]  
Eberhard R.C., 1995, P 6 INT S MICR HUM S, P39, DOI DOI 10.1109/MHS.1995.494215
[8]   Flux (1): A virtual synthesis scheme for fragment-based de novo design [J].
Fechner, U ;
Schneider, G .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (02) :699-707
[9]   Evaluation of distance metrics for ligand-based similarity searching [J].
Fechner, U ;
Schneider, G .
CHEMBIOCHEM, 2004, 5 (04) :538-540
[10]   Optimization of a pharmacophore-based correlation vector descriptor for similarity searching [J].
Fechner, U ;
Schneider, G .
QSAR & COMBINATORIAL SCIENCE, 2004, 23 (01) :19-22